Skip to main content
. 2023 Dec 14;14:7812. doi: 10.1038/s41467-023-43510-w

Fig. 2. DMPS and marimastat, but not varespladib, inhibit the potency of certain cytotoxic snake venoms in adherent HaCaT cells.

Fig. 2

Serial dilutions of venoms (2.5–200 µg/mL) were pre-incubated with the MTC½ of DMPS, marimastat, varespladib, or vehicle control for 30 minutes, after which HaCaT cells were exposed to the treatments for 24 hours followed by MTT cell viability assays, from which venom concentration-response curves and their associated IC50 values were calculated. Panels show venom from a B. arietans, b C. atrox, c E. carinatus, d E. ocellatus, e East African N. nigricollis, and f West African N. nigricollis. * Signifies that the IC50 is significantly higher than that of the vehicle control for that venom as determined by a one-way ANOVA followed by Dunnett’s multiple comparisons test (P < 0.05, n = 3 biologically independent cell experiments). ANOVA statistics for individual statistically analysed graphs are: a F(3,8) = 1.057, P = 0.4195; b F(3,8) = 37.16, P = 0.000048; c F(3,8) = 21.17, P = 0.0004; d F(3,8) = 20.34, P = 0.0004; e F(3,8) = 8.757, P = 0.0066; f F(3,8) = 2.998, P = 0.0952. Data are presented as mean values ± SD and the individual values for each trial are shown as points within each of the bar graphs. Source data are provided as a Source Data file.